During the same period in the prior year, the business earned $1.39 earnings per share. equities research analysts anticipate that Stryker Corporation will post 6.47 EPS for the current fiscal year. Two analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have assigned a buy rating to the company.
Shares of Entellus Medical Inc (NASDAQ:ENTL) have been given a consensus recommendation of "Hold" by the nine brokerages that are now covering the firm, MarketBeat.com reports.
A number of equities analysts have commented on the company. SunTrust Banks restated a "buy" rating and set a $161.00 target price on shares of Stryker in a research report on Friday, November 17th. Robert W. Baird raised Stryker from a "neutral" rating to an "outperform" rating and raised their price objective for the stock from $161.00 to $173.00 in a research note on Thursday, November 16th. Fifth Third Bancorp raised its holdings in Stryker by 0.7% during the 1st quarter.
Stryker Corporation (SYK) traded down $0.33 during trading hours on Wednesday, reaching $152.03. The company's stock had a trading volume of 997,961 shares, compared to its average volume of 1,176,642. The company has a quick ratio of 1.61, a current ratio of 2.37 and a debt-to-equity ratio of 0.63. The firm has a market capitalization of $57,910.00, a price-to-earnings ratio of 24.63, a P/E/G ratio of 2.45 and a beta of 0.79. The company had revenue of $19.11 million during the quarter, compared to analyst estimates of $19.61 million.
The transaction is expected to dent Stryker's 2018 adjusted net earnings per share by about 4 cents and then add to per-share earnings afterward. Entellus Medical's revenue was up 13.0% on a year-over-year basis.
The directors of Stryker Corp. have declared a fourth-quarter that is 11 percent higher than a year ago.
SYK has been the subject of several other reports. If you are reading this report on another domain, it was illegally copied and republished in violation of US and worldwide copyright & trademark legislation.
In related news, insider Lonny J. Carpenter sold 5,000 shares of the company's stock in a transaction dated Friday, November 3rd. The stock was acquired at an average price of $12.24 per share, with a total value of $122,400.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Motco raised its stake in shares of Stryker by 50.7% in the second quarter. Teachers Advisors LLC raised its stake in Entellus Medical by 17.4% in the first quarter. The medical technology company reported $1.52 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.50 by $0.02. Boston Financial Mangement LLC increased its holdings in shares of Stryker Corporation by 1.0% in the first quarter. San Francisco Sentry Investment Group CA now owns 1,005 shares of the medical technology company's stock valued at $143,000 after acquiring an additional 325 shares in the last quarter. Global Financial Private Capital LLC bought a new stake in shares of Stryker Corporation in the first quarter worth about $1,851,000. Finally, Weatherstone Capital Management increased its holdings in shares of Stryker Corporation by 2.0% in the first quarter. Weatherstone Capital Management now owns 2,393 shares of the medical technology company's stock worth $315,000 after acquiring an additional 46 shares in the last quarter. Hedge funds and other institutional investors own 74.97% of the company's stock.
Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products.